Nano-hydrogel embedded with quercetin and oleic acid as a new formulation in the treatment of diabetic foot ulcer : A pilot study
© 2019 Medicalhelplines.com Inc and John Wiley & Sons Ltd..
Wound healing, especially diabetic ones, is a relevant clinical problem, so it is not surprising that surgical procedures are often needed. To overcome invasive procedures, several strategies with drugs or natural compound are used. Recently, in an experimental study, we described an increase in keratinocyte proliferation after their exposition to quercetin plus oleic acid. In the present clinical study, we evaluated both the clinical efficacy and the safety of nano-hydrogel embedded with quercetin and oleic acid in the treatment of lower limb skin wound in patients with diabetes mellitus (DM). Fifty-six DM patients (28 men and 28 women, mean age 61.7 ± 9.2 years) unsuccessfully treated with mechanical compression were enrolled and randomised to receive an add on treatment with hyaluronic acid (0.2%) or nano-hydrogel embedded with quercetin and oleic acid. The treatment with nano-hydrogel embedded with quercetin and oleic acid significantly (P < .01) reduced the wound healing time, in comparison to hyaluronic acid (0.2%) without developing of adverse drug reactions, suggesting that this formulation could be used in the management of wound healing even if other clinical trials must be performed in order to validate this observation.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:17 |
---|---|
Enthalten in: |
International wound journal - 17(2020), 2 vom: 17. Apr., Seite 485-490 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Gallelli, Giuseppe [VerfasserIn] |
---|
Links: |
---|
Themen: |
2UMI9U37CP |
---|
Anmerkungen: |
Date Completed 07.01.2021 Date Revised 03.07.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1111/iwj.13299 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM30476261X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM30476261X | ||
003 | DE-627 | ||
005 | 20231225115659.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1111/iwj.13299 |2 doi | |
028 | 5 | 2 | |a pubmed24n1015.xml |
035 | |a (DE-627)NLM30476261X | ||
035 | |a (NLM)31876118 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Gallelli, Giuseppe |e verfasserin |4 aut | |
245 | 1 | 0 | |a Nano-hydrogel embedded with quercetin and oleic acid as a new formulation in the treatment of diabetic foot ulcer |b A pilot study |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 07.01.2021 | ||
500 | |a Date Revised 03.07.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2019 Medicalhelplines.com Inc and John Wiley & Sons Ltd. | ||
520 | |a Wound healing, especially diabetic ones, is a relevant clinical problem, so it is not surprising that surgical procedures are often needed. To overcome invasive procedures, several strategies with drugs or natural compound are used. Recently, in an experimental study, we described an increase in keratinocyte proliferation after their exposition to quercetin plus oleic acid. In the present clinical study, we evaluated both the clinical efficacy and the safety of nano-hydrogel embedded with quercetin and oleic acid in the treatment of lower limb skin wound in patients with diabetes mellitus (DM). Fifty-six DM patients (28 men and 28 women, mean age 61.7 ± 9.2 years) unsuccessfully treated with mechanical compression were enrolled and randomised to receive an add on treatment with hyaluronic acid (0.2%) or nano-hydrogel embedded with quercetin and oleic acid. The treatment with nano-hydrogel embedded with quercetin and oleic acid significantly (P < .01) reduced the wound healing time, in comparison to hyaluronic acid (0.2%) without developing of adverse drug reactions, suggesting that this formulation could be used in the management of wound healing even if other clinical trials must be performed in order to validate this observation | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Randomized Controlled Trial | |
650 | 4 | |a hyaluronic acid | |
650 | 4 | |a nano-hydrogel | |
650 | 4 | |a oleic acid | |
650 | 4 | |a quercetin | |
650 | 4 | |a wound healing | |
650 | 7 | |a Antioxidants |2 NLM | |
650 | 7 | |a Drug Combinations |2 NLM | |
650 | 7 | |a Hydrogels |2 NLM | |
650 | 7 | |a Oleic Acid |2 NLM | |
650 | 7 | |a 2UMI9U37CP |2 NLM | |
650 | 7 | |a Quercetin |2 NLM | |
650 | 7 | |a 9IKM0I5T1E |2 NLM | |
700 | 1 | |a Cione, Erika |e verfasserin |4 aut | |
700 | 1 | |a Serra, Raffaele |e verfasserin |4 aut | |
700 | 1 | |a Leo, Antonio |e verfasserin |4 aut | |
700 | 1 | |a Citraro, Rita |e verfasserin |4 aut | |
700 | 1 | |a Matricardi, Pietro |e verfasserin |4 aut | |
700 | 1 | |a Di Meo, Chiara |e verfasserin |4 aut | |
700 | 1 | |a Bisceglia, Francesco |e verfasserin |4 aut | |
700 | 1 | |a Caroleo, Maria C |e verfasserin |4 aut | |
700 | 1 | |a Basile, Sonia |e verfasserin |4 aut | |
700 | 1 | |a Gallelli, Luca |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t International wound journal |d 2004 |g 17(2020), 2 vom: 17. Apr., Seite 485-490 |w (DE-627)NLM162044909 |x 1742-481X |7 nnns |
773 | 1 | 8 | |g volume:17 |g year:2020 |g number:2 |g day:17 |g month:04 |g pages:485-490 |
856 | 4 | 0 | |u http://dx.doi.org/10.1111/iwj.13299 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 17 |j 2020 |e 2 |b 17 |c 04 |h 485-490 |